Streptococcus suis meningoencephalitis diagnosed with metagenomic next-generation sequencing: A case report with

Zai-Jie Jiang1, Jian-Chen Hong2, Qing-Xi Tang1

  • 1Department of Neurology and Institute of Neurology of First Affiliated Hospital, Institute of Neuroscience, and Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, 350005, China.

Insights

Rapid diagnosis of Streptococcus suis meningoencephalitis is crucial. Metagenomic next-generation sequencing (mNGS) successfully identified Streptococcus suis in a patient where traditional methods failed, highlighting mNGS as a valuable tool for rare central nervous system infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Neurology

Background:

  • Streptococcus suis is an emerging zoonotic pathogen causing meningoencephalitis in humans.
  • Timely diagnosis of S. suis meningoencephalitis is essential for effective patient treatment.
  • Conventional diagnostic methods like bacterial culture and Gram staining exhibit low sensitivity for S. suis.

Conclusions:

  • Metagenomic next-generation sequencing (mNGS) offers a sensitive and rapid diagnostic approach for S. suis meningoencephalitis.
  • mNGS is a promising tool for the diagnosis of rare infectious diseases affecting the central nervous system.
  • This case underscores the importance of advanced molecular techniques when conventional methods are insufficient.